302 related articles for article (PubMed ID: 31610665)
41. Colorectal peritoneal metastases: Optimal management review.
Sánchez-Hidalgo JM; Rodríguez-Ortiz L; Arjona-Sánchez Á; Rufián-Peña S; Casado-Adam Á; Cosano-Álvarez A; Briceño-Delgado J
World J Gastroenterol; 2019 Jul; 25(27):3484-3502. PubMed ID: 31367152
[TBL] [Abstract][Full Text] [Related]
42. Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.
Ramírez Plaza CP; Cobo Dols MA; Gómez Portilla A; de la Fuente Perucho A
Clin Transl Oncol; 2005 Nov; 7(10):421-31. PubMed ID: 16373050
[TBL] [Abstract][Full Text] [Related]
43. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin.
Kok NF; de Hingh IH
Br J Surg; 2017 Mar; 104(4):313-315. PubMed ID: 28112791
[No Abstract] [Full Text] [Related]
44. Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine.
Vanounou T; Garfinkle R
Ann Surg Oncol; 2016 Aug; 23(8):2556-61. PubMed ID: 26957499
[TBL] [Abstract][Full Text] [Related]
45. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
46. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
[TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
[TBL] [Abstract][Full Text] [Related]
48. Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review.
Baratti D; Kusamura S; Pietrantonio F; Guaglio M; Niger M; Deraco M
Crit Rev Oncol Hematol; 2016 Apr; 100():209-22. PubMed ID: 26867984
[TBL] [Abstract][Full Text] [Related]
49. Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.
Simkens GA; van Oudheusden TR; Luyer MD; Nienhuijs SW; Nieuwenhuijzen GA; Rutten HJ; de Hingh IH
Ann Surg Oncol; 2016 Mar; 23(3):833-41. PubMed ID: 26442921
[TBL] [Abstract][Full Text] [Related]
50. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience.
Bartoş A; Bartoş D; Raluca S; Mitre C; Hadade A; Iancu I; Cioltean C; Iancu C; Militaru C; Părău A; Breazu C
Chirurgia (Bucur); 2019; 114(2):222-233. PubMed ID: 31060655
[No Abstract] [Full Text] [Related]
51. Simultaneous Parenchyma-Preserving Liver Resection, Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stage IV Colorectal Cancer.
Abreu de Carvalho LF; Scuderi V; Maes H; Cupo P; Geerts B; Van Bockstal M; Gremonprez F; Willaert W; Pattyn P; Troisi R; Ceelen W
Acta Chir Belg; 2015; 115(4):261-7. PubMed ID: 26324026
[TBL] [Abstract][Full Text] [Related]
52. Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center.
Park SY; Choi GS; Park JS; Kim HJ; Ryuk JP; Yun SH; Kim JG; Kang BW
Surg Endosc; 2014 May; 28(5):1555-62. PubMed ID: 24368743
[TBL] [Abstract][Full Text] [Related]
53. P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Yong ZZ; Tan GHC; Shannon N; Chia C; Teo MCC
World J Surg Oncol; 2019 Aug; 17(1):138. PubMed ID: 31391066
[TBL] [Abstract][Full Text] [Related]
54. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.
Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spilioitis J; Torres-Melero J; Turaga K; Trout R
Ann Surg Oncol; 2014 Dec; 21(13):4195-201. PubMed ID: 24854493
[TBL] [Abstract][Full Text] [Related]
55. Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Enblad M; Ghanipour L; Cashin PH
Int J Hyperthermia; 2018 Dec; 34(8):1390-1395. PubMed ID: 29695209
[TBL] [Abstract][Full Text] [Related]
56. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Iversen LH; Rasmussen PC; Laurberg S
Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
[TBL] [Abstract][Full Text] [Related]
57. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study.
Burnett A; Lecompte MA; Trabulsi N; Dubé P; Gervais MK; Trilling B; Cloutier AS; Sideris L
World J Surg Oncol; 2019 May; 17(1):83. PubMed ID: 31092250
[TBL] [Abstract][Full Text] [Related]
58. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial.
Cashin PH; Mahteme H; Spång N; Syk I; Frödin JE; Torkzad M; Glimelius B; Graf W
Eur J Cancer; 2016 Jan; 53():155-62. PubMed ID: 26751236
[TBL] [Abstract][Full Text] [Related]
59. Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin.
Eveno C; Passot G; Goéré D; Soyer P; Gayat E; Glehen O; Elias D; Pocard M
Ann Surg Oncol; 2014 Jun; 21(6):1792-800. PubMed ID: 24337648
[TBL] [Abstract][Full Text] [Related]
60. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
Prada-Villaverde A; Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spiliotis J; Torres-Melero J; Turaga K; Trout R
J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
